Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 358

1.

Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma.

Lin BM, Wang H, D'Souza G, Zhang Z, Fakhry C, Joseph AW, Drake VE, Sanguineti G, Westra WH, Pai SI.

Cancer. 2013 Oct 1;119(19):3462-71. doi: 10.1002/cncr.28250. Epub 2013 Jul 16.

2.

The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.

Oguejiofor KK, Hall JS, Mani N, Douglas C, Slevin NJ, Homer J, Hall G, West CM.

Clin Oncol (R Coll Radiol). 2013 Nov;25(11):630-8. doi: 10.1016/j.clon.2013.07.003. Epub 2013 Jul 31.

PMID:
23916365
3.

T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.

Mackenzie P, Pryor D, Burmeister E, Foote M, Panizza B, Burmeister B, Porceddu S.

Clin Oncol (R Coll Radiol). 2014 Oct;26(10):643-7. doi: 10.1016/j.clon.2014.06.007. Epub 2014 Jul 4.

PMID:
25001635
4.

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

Rischin D, Young RJ, Fisher R, Fox SB, Le QT, Peters LJ, Solomon B, Choi J, O'Sullivan B, Kenny LM, McArthur GA.

J Clin Oncol. 2010 Sep 20;28(27):4142-8. doi: 10.1200/JCO.2010.29.2904. Epub 2010 Aug 9.

5.

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.

Sedaghat AR, Zhang Z, Begum S, Palermo R, Best S, Ulmer KM, Levine M, Zinreich E, Messing BP, Gold D, Wu AA, Niparko KJ, Kowalski J, Hirata RM, Saunders JR, Westra WH, Pai SI.

Laryngoscope. 2009 Aug;119(8):1542-9. doi: 10.1002/lary.20533.

PMID:
19522004
6.

High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.

Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr.

Am J Surg Pathol. 2011 Sep;35(9):1343-50. doi: 10.1097/PAS.0b013e318220e59d.

PMID:
21836494
7.

Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.

Rios Velazquez E, Hoebers F, Aerts HJ, Rietbergen MM, Brakenhoff RH, Leemans RC, Speel EJ, Straetmans J, Kremer B, Lambin P.

Radiother Oncol. 2014 Dec;113(3):324-30. doi: 10.1016/j.radonc.2014.09.005. Epub 2014 Oct 24.

8.

Biomarkers of HPV in head and neck squamous cell carcinoma.

Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT.

Cancer Res. 2012 Oct 1;72(19):5004-13. doi: 10.1158/0008-5472.CAN-11-3277. Epub 2012 Sep 18.

9.

Staging and treatment of oropharyngeal cancer in the human papillomavirus era.

Ward MJ, Mellows T, Harris S, Webb A, Patel NN, Cox HJ, Piper K, Ottensmeier CH, Thomas GJ, King EV.

Head Neck. 2015 Jul;37(7):1002-13. doi: 10.1002/hed.23697. Epub 2014 Jul 12.

PMID:
24753272
10.

Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.

Alluri KC, Tahari AK, Wahl RL, Koch W, Chung CH, Subramaniam RM.

AJR Am J Roentgenol. 2014 Oct;203(4):897-903. doi: 10.2214/AJR.14.12497.

11.

Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival.

Näsman A, Nordfors C, Grün N, Munck-Wikland E, Ramqvist T, Marklund L, Lindquist D, Dalianis T.

Cancer Med. 2013 Aug;2(4):507-18. doi: 10.1002/cam4.90. Epub 2013 Jun 14.

12.

Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.

Liu J, Zhang M, Rose B, Veillard AS, Jones D, Zhang X, Soon Lee C, Milross C, Hong A.

Ann Surg Oncol. 2015;22(6):1893-900. doi: 10.1245/s10434-014-4237-x. Epub 2014 Nov 18.

PMID:
25404475
13.

Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma.

Guo M, Khanna A, Dhillon J, Patel SJ, Feng J, Williams MD, Bell DM, Gong Y, Katz RL, Sturgis EM, Staerkel GA.

Cancer Cytopathol. 2014 Feb;122(2):96-103. doi: 10.1002/cncy.21375. Epub 2013 Dec 11.

14.

Changing trends in human papillomavirus-associated head and neck squamous cell carcinoma.

Wang XI, Thomas J, Zhang S.

Ann Diagn Pathol. 2012 Jan;16(1):7-12. doi: 10.1016/j.anndiagpath.2011.07.003. Epub 2011 Oct 15.

PMID:
22001331
15.

Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.

Young RJ, Urban D, Angel C, Corry J, Lyons B, Vallance N, Kleid S, Iseli TA, Solomon B, Rischin D.

Br J Cancer. 2015 Mar 17;112(6):1098-104. doi: 10.1038/bjc.2015.59.

16.

Relationship between insulin-like growth factor-1 receptor and human papillomavirus in patients with oropharyngeal cancer.

Matsumoto F, Fujimaki M, Ohba S, Kojima M, Yokoyama J, Ikeda K.

Head Neck. 2015 Jul;37(7):977-81. doi: 10.1002/hed.23702. Epub 2014 Jun 27.

PMID:
24700733
17.

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D.

J Natl Cancer Inst. 2000 May 3;92(9):709-20.

18.

Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.

Patel KR, Chernock RD, Zhang TR, Wang X, El-Mofty SK, Lewis JS Jr.

Hum Pathol. 2013 Nov;44(11):2385-92. doi: 10.1016/j.humpath.2013.07.011. Epub 2013 Sep 24.

PMID:
24071016
19.

Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.

Mizumachi T, Kano S, Sakashita T, Hatakeyama H, Suzuki S, Homma A, Oridate N, Fukuda S.

Int J Clin Oncol. 2013 Oct;18(5):824-8. doi: 10.1007/s10147-012-0469-6. Epub 2012 Aug 31.

PMID:
22936564
20.

Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.

Habbous S, Harland LT, La Delfa A, Fadhel E, Xu W, Liu FF, Goldstein D, Waldron J, Huang SH, O'Sullivan B, Liu G.

Head Neck. 2014 Jun;36(6):802-10. doi: 10.1002/hed.23360. Epub 2013 Jul 30.

PMID:
23616414
Items per page

Supplemental Content

Write to the Help Desk